Deals
Gide’s Casablanca and Brussels offices assisted Renault Trucks (Volvo group) on the divestment of its Moroccan subsidiary, Renault Trucks Maroc, to longstanding distribution partner Groupe Bernard Hayot (GBH).
The closing took place on 1 November 2017, following the approval of the transaction by the Moroccan competition authorities.
A long-standing distributor of Renault Trucks in the French Antilles, Reunion Island, Ghana and the Ivory Coast, GBH intends to expand its development in Africa and strengthen its offer on the Moroccan market. GBH was already present in North Africa with the Hertz franchise in Morocco and the distribution of Citroën and
Danish environmental services group Reconor, a portfolio company of private equity firm Agilitas, has completed its third acquisition of 2017. Financial terms of the deal have not been announced.
Reconor, based in Farum, Denmark, is further strengthening its activities in Southern Jutland with the acquisition of the business of 7-9-13 Recycling, a waste collection and recycling company established in 2000 and counting more than 250 customers, served with over 250 mini-containers and over 85 skips. The acquisition follows the purchase of Mijodan a/s, also based in Southern Jutland, in October 2017 and the acquisition of Lotra a/s in June 2017.
Noerr had advised Bridgepoint and its portfolio company WiggleCRC on the acquisition of Bike24 from the private equity fund Riverside.
Bike24 is an e-commerce platform for bicycles, sports equipment and clothing active in Germany, Austria and Switzerland. The company, which is based in Dresden, was taken over in 2011 by Bridgepoint and is one of the fastest-growing online bicycle retailers in Europe.
The Noerr team led by Munich partner Georg Schneider advised Bridgepoint and WiggleCRC comprehensively on all German aspects of the transaction. Travers Smith advised on English law.
Aster has raised an additional EUR240 million bringing its total funds under management to EUR500 million. A specialist in digital transformation and industries of the future, the investment company provides support to growing companies in the sectors of energy, mobility and industry.
Building from a Business Hub, a true acceleration platform serving entrepreneurs, Aster provides them with support to jump-start their development projects and benefit from corporate investor networks.
A EUR240 million capital increase is to be invested primarily in Europe and the United States. The EUR240 million in capital raised in the first closing by several industrial players
Medigold Health, a provider of occupational health and corporate wellbeing services, has received a GBP9.5 million investment from the Business Growth Fund (BGF) to support its ambitious growth plans.
The Northampton-based business has used some of the funds to make two strategic acquisitions, buying IMASS, an occupational health provider with a focus in the South West of England and on public sector customers, and Hampton Knight, a specialist provider of alcohol and drug screening services throughout the UK.
Founded 20 years ago by Dr Mike Goldsmith, and now under the leadership of his son Alex Goldsmith, Medigold Health provides
Five Capital, a subsidiary of CDC International Capital based in Dubai and Riyadh, has entered into exclusive negotiations with Diwanee, a subsidiary of Webedia Group, French specialist in theme-based online publishing, for a merger between Diwanee and Uturn Entertainment, a Saudi digital content provider.
Further discussions between the parties will take place in the coming weeks with a view to concluding a final agreement. This transaction, if agreed, will be subject to board approval from each concerned party and would be undertaken in full compliance with current local and international laws and regulations.
Based in Jeddah, the company Uturn
Pure Harvest Smart Farms (Pure Harvest), a tech-enabled arid climate agribusiness based in Abu Dhabi in the United Arab Emirates, has secured seed investment of USD4.5 million in a financing round that was significantly oversubscribed.
This follows an earlier USD1.1 million pre-seed round led by Abu Dhabi-based Shorooq Investments.
Venture financing was provided by a leading federal government-backed fund, the Company’s technology partners, and a consortium of Angel investors from around the world, all of whom were strongly aligned with the Company’s mission – to offer a true & tangible food security solution to the region by deploying advanced
Trilantic Europe, a private equity firm focused on mid-market transactions in Europe, has acquired Oberberg Group, an operator of psychotherapy, psychiatry and psychosomatic acute clinics in Germany, with a focus on treatments for depression and addictions.
The transaction allows Trilantic Europe to invest in a leading and specialised healthcare operator in the German private psychotherapy market based on an attractive portfolio of clinics and a unique therapy concept.
Oberberg Group operates nine clinics at eight locations with approximately 560 beds focused on privately insured patients. The clinics operate under different brands including Oberberg Kliniken, SOMNIA Privatkliniken, Rhein-Jura Klinik and
Alter Domus, a provider of fund and corporate services to alternative investment managers, is to acquire Cortland Capital Markets Services (Cortland) in the US. The terms of the transaction have not been disclosed.
Headquartered in Chicago and with offices in New York, London, Los Angeles, Austin, Indianapolis, and China, Cortland is a leading independent investment servicing company providing third – party fund administration and middle and back – office outsourcing to financial institutions, including alternative investment managers, real estate private equity firms and cred it funds. It currently has over USD180 billion of assets under administration. The firm was founded
Sixth Element Capital (6EC), a UK based fund manager established to manage investments for the GBP70 million CRT Pioneer Fund, has made a GBP3 million investment in NeoPhore Ltd, a spin out from Cambridge, UK based PhoreMost Ltd.
NeoPhore is focused on the discovery and development of novel small molecule therapies to treat cancer through stimulation of the immune system. The investment will be used to build on the discoveries already made by PhoreMost and its collaborators. NeoPhore’s drug target rationale is highly validated by genetic evidence in cancer patients and cellular models.
NeoPhore aims to exploit novel biological
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
